Christophe Pison,Adrien Tissot,Eric Bernasconi,Pierre-Joseph Royer,Antoine Roux,Angela Koutsokera,Benjamin Coiffard,Benjamin Renaud-Picard,Jérôme Le Pavec,Pierre Mordant,Xavier Demant,Thomas Villeneuve,Jean-Francois Mornex,Simona Nemska,Nelly Frossard,Olivier Brugière,Valérie Siroux,Benjamin J Marsland,Aurore Foureau,Karine Botturi,Eugenie Durand,Johann Pellet,Richard Danger,Charles Auffray,Sophie Brouard,Laurent Nicod,Antoine Magnan,Members of the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction consortia

Abstract:Background: Chronic lung allograft dysfunction (CLAD) is the leading cause of poor long-term survival after lung transplantation (LT). Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) aimed to predict CLAD. Methods: To predict CLAD, we investigated the clinicome of patients with LT; the exposome through assessment of airway microbiota in bronchoalveolar lavage cells and air pollution studies; the immunome with works on activation of dendritic cells, the role of T cells to promote the secretion of matrix metalloproteinase-9, and subpopulations of T and B cells; genome polymorphisms; blood transcriptome; plasma proteome studies and assessment of MSK1 expression. Results: Clinicome: the best multivariate logistic regression analysis model for early-onset CLAD in 422 LT eligible patients generated a ROC curve with an area under the curve of 0.77. Exposome: chronic exposure to air pollutants appears deleterious on lung function levels in LT recipients (LTRs), might be modified by macrolides, and increases mortality. Our findings established a link between the lung microbial ecosystem, human lung function, and clinical stability post-transplant. Immunome: a decreased expression of CLEC1A in human lung transplants is predictive of the development of chronic rejection and associated with a higher level of interleukin 17A; Immune cells support airway remodeling through the production of plasma MMP-9 levels, a potential predictive biomarker of CLAD. Blood CD9-expressing B cells appear to favor the maintenance of long-term stable graft function and are a potential new predictive biomarker of BOS-free survival. An early increase of blood CD4 + CD57 + ILT2+ T cells after LT may be associated with CLAD onset. Genome: Donor Club cell secretory protein G38A polymorphism is associated with a decreased risk of severe primary graft dysfunction after LT. Transcriptome: blood POU class 2 associating factor 1, T-cell leukemia/lymphoma domain, and B cell lymphocytes, were validated as predictive biomarkers of CLAD phenotypes more than 6 months before diagnosis. Proteome: blood A2MG is an independent predictor of CLAD, and MSK1 kinase overexpression is either a marker or a potential therapeutic target in CLAD. Conclusion: Systems prediction of Chronic Lung Allograft Dysfunction generated multiple fingerprints that enabled the development of predictors of CLAD. These results open the way to the integration of these fingerprints into a predictive handprint.

Macrophage and CD8 T Cell Discordance are Associated with Acute Lung Allograft Dysfunction Progression

Emergence of a senescent and inflammatory pulmonary CD4 T cell population prior to lung allograft failure

Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.

High-dimensional tissue profiling of immune cell responses in chronic lung allograft dysfunction

Unique Changes in the Lung Microbiome following the Development of Chronic Lung Allograft Dysfunction

Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients

Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study

Understanding the Impact of Macrophages on Lung Transplant Outcomes

SLAMF8 Participates in Acute Renal Transplant Rejection <i>via</i> TLR4 Pathway on Pro-Inflammatory Macrophages

Insights from T Cell Profiling in BAL and PBMC

Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients

Lymphocytic Airway Inflammation in Lung Allografts

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts

The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Patients with Chronic Rejection

NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients

Single-cell multi-omic analysis of post-transplant mesenchymal cells reveals molecular signatures and putative regulators of lung fibrosis

Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system

Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation

Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation

Depletion of Alveolar Macrophages Abrogates Prolongation of Cardiac Allograft Survival Induced by Intratracheal Delivery of Alloantigen

Local intragraft humoral immune responses in chronic lung allograft dysfunction